SARS-CoV-2 specific antibodies / Distributed Bio - LARVOL DELTA

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers. (PubMed, Nat Commun) - "The modularity of the platform also makes it relevant for rapid evaluation against other infectious diseases of global health importance. Neutralizing antibodies are a promising therapeutic for SARS-CoV-2."

Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

Newly added product (Genetic Engineering & Biotechnology News) - Preclinical, Novel Coronavirus Disease

Pipeline update